Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Theia Biosciences
San Francisco, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Theia Biosciences is a private ophthalmology-focused biotechnology company formed as a joint venture between Atomwise and UC Riverside scientist John Jefferson Perry. The company was created to discover and develop small-molecule inhibitors of HtrA serine peptidase 1 (HTRA1) for age-related macular degeneration, initially targeting wet AMD with potential expansion into dry AMD. Its discovery approach leveraged Atomwise's AI-driven AtomNet screening technology together with academic research from Perry's laboratory. Publicly available information suggests Theia Biosciences remains an early-stage private company with a narrow, ophthalmology-centered pipeline and no disclosed clinical-stage assets.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
AtomwiseUniversity of California, Riverside
Beyond the preview
Go deeper on Theia Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theia Biosciences.